Travere Cash And Short Term Investments from 2010 to 2024

TVTX Stock  USD 7.42  0.40  5.70%   
Travere Therapeutics Cash And Short Term Investments yearly trend continues to be fairly stable with very little volatility. Cash And Short Term Investments will likely drop to about 284.6 M in 2024. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2010-09-30
Previous Quarter
566.9 M
Current Value
441 M
Quarterly Volatility
214.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Travere Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Travere main balance sheet or income statement drivers, such as Interest Expense of 16.4 M, Selling General Administrative of 278.8 M or Other Operating Expenses of 548.1 M, as well as many exotic indicators such as Price To Sales Ratio of 6.88, Dividend Yield of 0.0 or PTB Ratio of 3.16. Travere financial statements analysis is a perfect complement when working with Travere Therapeutics Valuation or Volatility modules.
  
This module can also supplement Travere Therapeutics' financial leverage analysis and stock options assessment as well as various Travere Therapeutics Technical models . Check out the analysis of Travere Therapeutics Correlation against competitors.
For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.

Latest Travere Therapeutics' Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Travere Therapeutics over the last few years. Short Term Investments is an account in the current assets section of Travere Therapeutics balance sheet. This account contains Travere Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Travere Therapeutics fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Travere Therapeutics' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Travere Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Travere Cash And Short Term Investments Regression Statistics

Arithmetic Mean260,413,863
Geometric Mean26,065,442
Coefficient Of Variation80.47
Mean Deviation173,801,239
Median284,558,195
Standard Deviation209,549,907
Sample Variance43911.2T
Range566.8M
R-Value0.87
Mean Square Error11672.5T
R-Squared0.75
Significance0.000028
Slope40,664,733
Total Sum of Squares614756.3T

Travere Cash And Short Term Investments History

2024284.6 M
2023566.9 M
2022450.2 M
2021552.9 M
2020361.6 M
2019398.5 M
2018471.5 M

About Travere Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Travere Therapeutics income statement, its balance sheet, and the statement of cash flows. Travere Therapeutics investors use historical funamental indicators, such as Travere Therapeutics's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Travere Therapeutics investors may use each financial statement separately, they are all related. The changes in Travere Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Travere Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Travere Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Travere Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments566.9 M284.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Travere Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Travere Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Travere Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Travere Therapeutics Stock:
Check out the analysis of Travere Therapeutics Correlation against competitors.
For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Travere Stock analysis

When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Travere Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Travere Therapeutics. If investors know Travere will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Travere Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.41)
Revenue Per Share
2.035
Quarterly Revenue Growth
0.339
Return On Assets
(0.36)
Return On Equity
(3.16)
The market value of Travere Therapeutics is measured differently than its book value, which is the value of Travere that is recorded on the company's balance sheet. Investors also form their own opinion of Travere Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Travere Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Travere Therapeutics' market value can be influenced by many factors that don't directly affect Travere Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Travere Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Travere Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Travere Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.